Focus: Psomagen is a biotechnology company specializing in genetic sequencing focused on rare disease applications. The company operates from Rockville, MD with limited public disclosure of scale metrics.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Stable — net -2 jobs in 30d
0 added, 2 removed. Backfill posture.
Psomagen represents a speculative early-stage biotech opportunity with rare disease focus, but lack of disclosed financials, pipeline depth, and hiring activity introduces significant risk for career stability and visibility.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Psomagen
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Psomagen's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo